Osteotech Tissue Recall Traced To Equipment Malfunction In Electrical Storm
This article was originally published in The Gray Sheet
Osteotech is testing the rework procedure it developed to resterilize recalled and quarantined donor tissue and hopes to have the procedure validated and in place by year-end
You may also be interested in...
CDRH is reviewing potential risks associated with CryoValve heart valves in the wake of an Aug. 14 recall order for CryoLife human tissue products
Manufacturers of combination devices incorporating human cells or tissues will have until Jan. 19, 2003 to register with FDA, according to a final rule released by the agency Jan. 18.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.